Company
Just as Magic is science yet to be discovered, the Microbiota I-Center (MagIC) harnesses and translates the human microbiome into cutting-edge innovations for early disease detection and prevention. MagIC focuses on advancing science in the gut microbiome and promoting entrepreneurship. It is committed to developing a novel class of microbiome diagnostics and live biotherapeutics for common diseases including obesity, cancer, autism, inflammatory disorders, and COVID-19, that will not only transform the lives of patients and their families but also accelerate Hong Kong into a world-class microbiome biotechnology hub.
